These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 535300)

  • 1. [Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in related neuromuscular diseases (author's transl)].
    Tsujihata M; Hazama R; Ishii N; Ide Y; Takamori M
    Rinsho Shinkeigaku; 1979 Nov; 19(11):751-9. PubMed ID: 535300
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrastructural localization of acetylcholine receptor at the motor endplate: myasthenia gravis and other neuromuscular diseases.
    Tsujihata M; Hazama R; Ishii N; Ide Y; Takamori M
    Neurology; 1980 Nov; 30(11):1203-11. PubMed ID: 7191515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The motor end-plate in ocular and generalized myasthenia gravis: a quantitative ultrastructural study (author's transl)].
    Tsujihata M; Hazama R; Takamori M; Shibuya N; Mori K
    Rinsho Shinkeigaku; 1978 Mar; 18(3):149-56. PubMed ID: 668254
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
    Vincent A; Cull-Candy SG; Newsom-Davis J; Trautmann A; Molenaar PC; Polak RL
    Muscle Nerve; 1981; 4(4):306-18. PubMed ID: 7254233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.
    Engel AG; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
    Hohlfeld R; Wekerle H
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-plate acetylcholinesterase deficiency associated with small nerve terminals and reduced acetylcholine release. A new syndrome.
    Engel AG; Lambert EH; Gomez MR
    Int J Neurol; 1980; 14(1):73-86. PubMed ID: 6293992
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB; Appel SH
    Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuromuscular junction: recent developments.
    Bowman WC
    Eur J Anaesthesiol; 1985 Mar; 2(1):59-93. PubMed ID: 2410263
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assay of acetylcholine receptor antibodies in myasthenia gravis. A study of 329 sera (author's transl)].
    Morel E; Raimond F; Goulon-Goëau C; Berrih S; Vernet-Der-Garabedian B; Harb J; Bach JF
    Nouv Presse Med; 1982 May; 11(24):1849-54. PubMed ID: 7110933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis and pathophysiology of myasthenia gravis--role of anti-acetylcholine receptor antibody (author's transl)].
    Nishitani H; Noguchi S; Ohta K; Matsubara S
    No To Shinkei; 1980 Sep; 32(9):879-90. PubMed ID: 7437163
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of immune complexes at the motor endplate in myasthenia gravis].
    Tsujihata M; Yoshimura T; Satoh A; Hazama R; Mori M
    Rinsho Shinkeigaku; 1983 Sep; 23(9):735-43. PubMed ID: 6673871
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of myasthenic IgG on degradation of junctional acetylcholine receptor.
    Takeo G; Motomura M; Mats H; Ohishi K; Yoshimura T; Tsujihata M; Nagataki S
    Muscle Nerve; 1993 Aug; 16(8):840-8. PubMed ID: 8332137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 16. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis and pathophysiology of myasthenia gravis--electrophysiological, ultrastructural and immunological aspects of neuromuscular junctions (author's transl)].
    Takamori M; Tsujihata M; Ide Y; Eguchi K; Mine M
    No To Shinkei; 1980 Sep; 32(9):891-908. PubMed ID: 6254548
    [No Abstract]   [Full Text] [Related]  

  • 18. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
    Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
    Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effector-receptors relationship: acetylcholine and myasthenia gravis].
    Matsuda T; Takeyasu K; Yoshida H
    Nihon Rinsho; 1979; 37(8):3125-30. PubMed ID: 390184
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction.
    Guyon T; Levasseur P; Truffault F; Cottin C; Gaud C; Berrih-Aknin S
    J Clin Invest; 1994 Jul; 94(1):16-24. PubMed ID: 8040257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.